Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ethanol Locks for Central Venous Line Infections
NCT00680459Phase 3Terminated
- Sponsor
- Baystate Medical Center
- Start
- May 2008
- Primary completion
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ethanol in catheter-related bloodstream infection (CRBSI) (2 arms), sponsored by Baystate Medical Center. Primary endpoint: Clearance of Central Venous Line Infection at 6 days. Started May 2008; status: terminated.
02
Drugs
ethanol
03
Conditions
catheter-related bloodstream infection (CRBSI)
Beyond the preview
Go deeper on NCT00680459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00680459.